ReShape Lifesciences Inc. (RSLS)
USD 0.49
(29.26%)
USD 0.49
(29.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.29 Million USD | -16.64% |
| 2022 | -3.68 Million USD | 83.62% |
| 2021 | -22.48 Million USD | -806.69% |
| 2020 | -2.48 Million USD | -14.44% |
| 2019 | -2.16 Million USD | -384.21% |
| 2018 | 762.46 Thousand USD | 107.88% |
| 2017 | -9.67 Million USD | -205.47% |
| 2016 | -3.16 Million USD | 52.45% |
| 2015 | -6.66 Million USD | 22.94% |
| 2014 | -8.64 Million USD | 47.39% |
| 2013 | -16.42 Million USD | -30.13% |
| 2012 | -12.62 Million USD | 45.81% |
| 2011 | -23.29 Million USD | 6.56% |
| 2010 | -24.93 Million USD | -263.67% |
| 2009 | -6.85 Million USD | 7.15% |
| 2008 | -7.38 Million USD | 80.38% |
| 2007 | -37.63 Million USD | -186.01% |
| 2006 | -13.15 Million USD | -453.75% |
| 2005 | -2.37 Million USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.24 Million USD | 47.87% |
| 2024 Q2 | -937 Thousand USD | 62.63% |
| 2023 Q1 | -8.89 Million USD | -141.5% |
| 2023 FY | -4.29 Million USD | -16.64% |
| 2023 Q4 | -4.29 Million USD | -269.16% |
| 2023 Q3 | -1.16 Million USD | 72.68% |
| 2023 Q2 | -4.26 Million USD | 52.12% |
| 2022 Q4 | -3.68 Million USD | 37.46% |
| 2022 Q2 | -11.15 Million USD | 25.04% |
| 2022 Q1 | -14.88 Million USD | 33.81% |
| 2022 FY | -3.68 Million USD | 83.62% |
| 2022 Q3 | -5.89 Million USD | 47.19% |
| 2021 Q1 | -494 Thousand USD | 80.08% |
| 2021 FY | -22.48 Million USD | -806.69% |
| 2021 Q3 | -25.79 Million USD | 29.44% |
| 2021 Q2 | -36.56 Million USD | -7301.42% |
| 2021 Q4 | -22.48 Million USD | 12.84% |
| 2020 Q2 | -900 Thousand USD | 36.53% |
| 2020 FY | -2.48 Million USD | -14.44% |
| 2020 Q1 | -1.41 Million USD | 34.56% |
| 2020 Q4 | -2.48 Million USD | -90.04% |
| 2020 Q3 | -1.3 Million USD | -45.0% |
| 2019 Q3 | -6.88 Million USD | -103.19% |
| 2019 FY | -2.16 Million USD | -384.21% |
| 2019 Q4 | -2.16 Million USD | 68.5% |
| 2019 Q1 | 750 Thousand USD | -1.63% |
| 2019 Q2 | -3.38 Million USD | -551.47% |
| 2018 Q3 | 59.22 Thousand USD | 104.18% |
| 2018 Q1 | 120.71 Thousand USD | 101.25% |
| 2018 FY | 762.46 Thousand USD | 107.88% |
| 2018 Q4 | 762.46 Thousand USD | 1187.47% |
| 2018 Q2 | -1.41 Million USD | -1274.01% |
| 2017 Q1 | -18.61 Million USD | -487.7% |
| 2017 FY | -9.67 Million USD | -205.47% |
| 2017 Q4 | -9.67 Million USD | 58.12% |
| 2017 Q3 | -23.1 Million USD | -108.32% |
| 2017 Q2 | -11.08 Million USD | 40.42% |
| 2016 Q3 | -1.16 Million USD | -141.36% |
| 2016 Q4 | -3.16 Million USD | -171.73% |
| 2016 FY | -3.16 Million USD | 52.45% |
| 2016 Q2 | 2.81 Million USD | 808.88% |
| 2016 Q1 | -397.52 Thousand USD | 94.03% |
| 2015 Q4 | -6.66 Million USD | 45.68% |
| 2015 FY | -6.66 Million USD | 22.94% |
| 2015 Q1 | -9.44 Million USD | -9.24% |
| 2015 Q3 | -12.26 Million USD | -222.56% |
| 2015 Q2 | -3.8 Million USD | 59.74% |
| 2014 Q4 | -8.64 Million USD | 29.8% |
| 2014 FY | -8.64 Million USD | 47.39% |
| 2014 Q3 | -12.31 Million USD | 26.42% |
| 2014 Q2 | -16.73 Million USD | 9.71% |
| 2014 Q1 | -18.53 Million USD | -12.81% |
| 2013 Q2 | -14.3 Million USD | 27.24% |
| 2013 Q1 | -19.66 Million USD | -55.72% |
| 2013 Q4 | -16.42 Million USD | -23.4% |
| 2013 FY | -16.42 Million USD | -30.13% |
| 2013 Q3 | -13.31 Million USD | 6.92% |
| 2012 Q2 | -16.96 Million USD | -7.04% |
| 2012 Q4 | -12.62 Million USD | 28.19% |
| 2012 FY | -12.62 Million USD | 45.81% |
| 2012 Q1 | -15.85 Million USD | 31.97% |
| 2012 Q3 | -17.58 Million USD | -3.62% |
| 2011 Q4 | -23.29 Million USD | 12.88% |
| 2011 Q2 | -21.56 Million USD | 11.45% |
| 2011 Q3 | -26.74 Million USD | -24.0% |
| 2011 FY | -23.29 Million USD | 6.56% |
| 2011 Q1 | -24.35 Million USD | 2.33% |
| 2010 Q2 | -4.02 Million USD | 47.19% |
| 2010 Q4 | -24.93 Million USD | -270.96% |
| 2010 Q1 | -7.62 Million USD | -11.22% |
| 2010 FY | -24.93 Million USD | -263.67% |
| 2010 Q3 | -6.72 Million USD | -66.93% |
| 2009 FY | -6.85 Million USD | 7.15% |
| 2009 Q2 | -16.05 Million USD | 21.64% |
| 2009 Q4 | -6.85 Million USD | 31.8% |
| 2009 Q3 | -10.05 Million USD | 37.39% |
| 2009 Q1 | -20.49 Million USD | -177.5% |
| 2008 Q2 | -26.45 Million USD | 16.48% |
| 2008 Q4 | -7.38 Million USD | 40.03% |
| 2008 Q3 | -12.31 Million USD | 53.46% |
| 2008 FY | -7.38 Million USD | 80.38% |
| 2008 Q1 | -31.67 Million USD | 15.83% |
| 2007 FY | -37.63 Million USD | -186.01% |
| 2007 Q4 | -37.63 Million USD | -492.35% |
| 2007 Q3 | -6.35 Million USD | 0.0% |
| 2006 Q4 | -13.15 Million USD | 0.0% |
| 2006 FY | -13.15 Million USD | -453.75% |
| 2005 FY | -2.37 Million USD | 0.0% |
| 2005 Q4 | -2.37 Million USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 115.867% |
| BrainsWay Ltd. | -10.32 Million USD | 58.362% |
| Cerus Corporation | 84.35 Million USD | 105.094% |
| Envoy Medical, Inc. | -3.81 Million USD | -12.664% |
| electroCore, Inc. | -9.95 Million USD | 56.836% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 16.156% |
| IceCure Medical Ltd | -9.93 Million USD | 56.745% |
| Inogen, Inc. | -103.56 Million USD | 95.851% |
| OrthoPediatrics Corp. | -9.26 Million USD | 53.631% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -18.017% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 67.191% |
| MaxCyte, Inc. | -27.76 Million USD | 84.523% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 16.37% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -646.309% |
| Orthofix Medical Inc. | 96.44 Million USD | 104.456% |
| PAVmed Inc | 29.08 Million USD | 114.773% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 74.633% |
| RxSight, Inc. | -6.68 Million USD | 35.674% |
| Sight Sciences, Inc. | -102.71 Million USD | 95.817% |
| SI-BONE, Inc. | 5.72 Million USD | 175.109% |
| TELA Bio, Inc. | -3.94 Million USD | -8.812% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 107.496% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1320.739% |
| Acutus Medical, Inc. | 12.27 Million USD | 134.995% |
| Talis Biomedical Corporation | -57.06 Million USD | 92.47% |
| Spectral AI, Inc. | -3.5 Million USD | -22.736% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 91.053% |
| CVRx, Inc. | -59.95 Million USD | 92.833% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 316.567% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 436.324% |
| Bioventus Inc. | 372.51 Million USD | 101.154% |
| Venus Concept Inc. | 74.3 Million USD | 105.783% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 57.798% |
| LivaNova PLC | 62.53 Million USD | 106.872% |
| 908 Devices Inc. | -115.09 Million USD | 96.267% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.34% |
| Nemaura Medical Inc. | 9.92 Million USD | 143.295% |
| NeuroPace, Inc. | 54.33 Million USD | 107.908% |
| LENSAR, Inc. | -18.31 Million USD | 76.535% |
| Apyx Medical Corporation | -5.15 Million USD | 16.579% |
| Cutera, Inc. | 288.3 Million USD | 101.49% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 157.179% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1740.076% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 90.196% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 53.288% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.306% |
| Axonics, Inc. | -77.19 Million USD | 94.434% |
| Outset Medical, Inc. | 67.67 Million USD | 106.349% |
| IRIDEX Corporation | -4.28 Million USD | -0.21% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 97.586% |
| IRadimed Corporation | -47.71 Million USD | 90.995% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -42.003% |
| INVO Bioscience, Inc. | 8.45 Million USD | 150.845% |
| Telesis Bio, Inc. | 32.63 Million USD | 113.167% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -71.734% |
| Varex Imaging Corporation | 316.9 Million USD | 101.356% |
| Quipt Home Medical Corp. | 81.73 Million USD | 105.257% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -54.457% |
| Pulmonx Corporation | -42.36 Million USD | 89.856% |
| Dynatronics Corporation | 6.2 Million USD | 169.261% |
| Modular Medical, Inc. | -8.04 Million USD | 46.568% |
| Semler Scientific, Inc. | -57.13 Million USD | 92.479% |
| InMode Ltd. | -135.39 Million USD | 96.826% |
| Bruker Corporation | 891.3 Million USD | 100.482% |
| Cytosorbents Corporation | 4.18 Million USD | 202.75% |
| DexCom, Inc. | 2.02 Billion USD | 100.212% |
| Align Technology, Inc. | -840.47 Million USD | 99.489% |
| Viveve Medical, Inc. | -13.81 Million USD | 68.892% |
| ZimVie Inc. | 450.41 Million USD | 100.954% |
| Movano Inc. | -5.86 Million USD | 26.747% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 96.804% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -646.309% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 316.567% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 101.204% |
| Profound Medical Corp. | -18.17 Million USD | 76.362% |
| Insulet Corporation | 798.1 Million USD | 100.538% |
| enVVeno Medical Corporation | -2.21 Million USD | -93.733% |
| Surmodics, Inc. | -12.01 Million USD | 64.233% |
| iCAD, Inc. | -21.2 Million USD | 79.74% |
| Nuwellis, Inc. | -2.81 Million USD | -52.43% |
| Biotricity, Inc. | 23.09 Million USD | 118.608% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 104.588% |
| Aethlon Medical, Inc. | -4.5 Million USD | 4.546% |
| InspireMD, Inc. | -8.04 Million USD | 46.588% |
| PAVmed Inc. | 29.08 Million USD | 114.773% |
| BIOLASE, Inc. | 11.34 Million USD | 137.879% |
| Beyond Air, Inc. | 6.22 Million USD | 168.984% |
| FONAR Corporation | -14.66 Million USD | 70.7% |
| AxoGen, Inc. | 32.26 Million USD | 113.317% |
| Vivani Medical, Inc. | 42 Thousand USD | 10330.952% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 59.683% |
| Inari Medical, Inc. | -7.16 Million USD | 39.994% |
| UFP Technologies, Inc. | 40.77 Million USD | 110.539% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 240.03% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 9.941% |
| Tenon Medical, Inc. | -1.25 Million USD | -242.39% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 43.505% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 63.97% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.194% |
| Sintx Technologies, Inc. | 905 Thousand USD | 574.807% |
| NanoVibronix, Inc. | -3.27 Million USD | -31.086% |
| Quanterix Corporation | -132.95 Million USD | 96.768% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -54.457% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 80.787% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.57% |
| TransMedics Group, Inc. | 121.13 Million USD | 103.547% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 83.587% |
| NeuroMetrix, Inc. | -1.49 Million USD | -188.182% |
| Hyperfine, Inc. | -75.61 Million USD | 94.318% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 102.823% |
| Biomerica, Inc. | -3.38 Million USD | -26.942% |
| Bone Biologics Corporation | -3.02 Million USD | -41.976% |
| AVITA Medical, Inc. | -26.23 Million USD | 83.619% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -133.734% |
| Silk Road Medical, Inc | 64.42 Million USD | 106.67% |